Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:liprotamase
|
| gptkbp:alternativeName |
gptkb:ALTU-238
gptkb:liprotamase |
| gptkbp:clinicalTrialPhase |
Phase 3 (as of 2017)
|
| gptkbp:developedBy |
gptkb:Anthera_Pharmaceuticals
|
| gptkbp:intendedUse |
treatment of exocrine pancreatic insufficiency
|
| gptkbp:mechanismOfAction |
enzyme replacement
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
gptkb:investigational_drug
|
| gptkbp:targetAudience |
patients with cystic fibrosis
patients with chronic pancreatitis |
| gptkbp:bfsParent |
gptkb:Anthera_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sollpura
|